首页 工具
登录
购物车
Sonidegib diphosphate

Sonidegib diphosphate

产品编号 T15727   CAS 1218778-77-8
别名: NVP-LDE 225 diphosphate, Erismodegib diphosphate, LDE225 diphosphate

Sonidegib diphosphate (LDE225 diphosphate) 是 Smo 的选择性拮抗剂,能够抑制鼠 Smo (IC50:1.3 nM)和人 Smo (IC50:2.5 nM)。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Sonidegib diphosphate Chemical Structure
Sonidegib diphosphate, CAS 1218778-77-8
规格 价格/CNY 货期 数量
5 mg ¥ 413 现货
10 mg ¥ 497 现货
25 mg ¥ 766 现货
50 mg ¥ 997 现货
100 mg ¥ 1,810 现货
1 mL * 10 mM (in DMSO) ¥ 621 现货
其他形式的 Sonidegib diphosphate:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
Venetoclax限时半价
产品目录号及名称: Sonidegib diphosphate (T15727)
点击图片重新获取验证码
选择批次  
纯度: 100%
纯度: 99.86%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Sonidegib diphosphate (LDE225 diphosphate) is an effective and selective Smo antagonist (IC50: 1.3 nM and 2.5 nM for mouse and human Smo in a binding assay, respectively).
靶点活性 Smo:2.5 nM (IC50), Smo (mouse):1.3 nM (IC50)
体外活性 Erismodegib diphosphate, a small molecule, clinically investigated SMO inhibitor. Erismodegib diphosphate is used alone and in combination with Nilotinib, inhibits the Hh pathway in CD34+ chronic phase (CP)-chronic myeloid leukaemia (CML) cells, reducing the number and self-renewal capacity of CML leukaemia stem cell (LSC). In a similar fashion to cyclopamine, Erismodegib interacts directly with SMO, to reduce the expression of downstream Hh signaling targets. The IC50 values for Erismodegib diphosphate for the major human CYP450 drug-metabolizing enzymes are greater than 10 μM. Primary CD34+ CP-CML cells are cultured in serum-free media (SFM)±Erismodegib for 6, 24, and 72 hours (h). At 72 h, while there is variability between the biological samples, GLI1 is obviously downregulated following exposure to Erismodegib (10 nM; 0.78-fold and 100 nM; 0.73-fold, respectively (p<0.01)[2].
体内活性 Erismodegib diphosphate is a weak base with a measured pKa of 4.2 and exhibits relatively poor aqueous solubility. Erismodegib diphosphate demonstrates dose-related antitumor activity after 10 days of oral administration of a suspension of the diphosphate salt, in the subcutaneous Ptch+/-p53-/- medulloblastoma allograft mouse model. Bone marrow cells and spleen cells from a subset of treated mice are transplanted into secondary recipient mice. Erismodegib diphosphate (5 mg/kg/day; once daily) obviously inhibits tumor growth, corresponding to a T/C value of 33% (p<0.05 as compared to vehicle controls). Erismodegib affords 51 and 83% regression respectively when dosed at 10 and 20 mg/kg/day qd [1]. Transplantation of either bone marrow (BM) or spleen cells from mice treated with Erismodegib diphosphate+ Nilotinib results in reduced white cell count (WCC) and reduces leukaemia development in secondary recipients compared to Erismodegib or Nilotinib alone[2].
别名 NVP-LDE 225 diphosphate, Erismodegib diphosphate, LDE225 diphosphate
分子量 681.49
分子式 C26H32F3N3O11P2
CAS No. 1218778-77-8

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 99 mg/mL(145.27 mM)

H2O: Insoluble

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.4674 mL 7.3369 mL 14.6737 mL 36.6843 mL
5 mM 0.2935 mL 1.4674 mL 2.9347 mL 7.3369 mL
10 mM 0.1467 mL 0.7337 mL 1.4674 mL 3.6684 mL
20 mM 0.0734 mL 0.3668 mL 0.7337 mL 1.8342 mL
50 mM 0.0293 mL 0.1467 mL 0.2935 mL 0.7337 mL
100 mM 0.0147 mL 0.0734 mL 0.1467 mL 0.3668 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Pan S, et al. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. ACS Med Chem Lett. 2010 Mar 16;1(3):130-4. 2. Irvine DA, et al. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep. 2016 May 9;6:25476. 3. Ma W, et al. Reduced Smoothened level rescued Aβ-induced memory deficits and neuronal inflammation in animal models of Alzheimer's disease. J Genet Genomics. 2018 May 20;45(5):237-246.
LEQ506 20(S)-Hydroxycholesterol SANT-1 Taladegib Purmorphamine Sonidegib Jervine Halcinonide

相关化合物库

该产品包含在如下化合物库中:
抗癌临床化合物库 抗癌药物库 药物功能重定位化合物库 抗癌上市药物库 抗癌活性化合物库 抑制剂库 已知活性化合物库 经典已知活性库 干细胞分化化合物库 肝脏毒性化合物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Sonidegib diphosphate 1218778-77-8 Stem Cells Smo NVP-LDE225 diphosphate LDE225 NVP-LDE 225 diphosphate LDE-225 Erismodegib Diphosphate Inhibitor Smoothened Sonidegib Diphosphate Erismodegib NVP-LDE-225 Diphosphate inhibit LDE 225 Erismodegib diphosphate LDE-225 Diphosphate NVP-LDE 225 NVP-LDE225 Diphosphate Sonidegib NVP-LDE-225 NVP-LDE225 LDE225 diphosphate LDE 225 Diphosphate NVP-LDE 225 Diphosphate LDE225 Diphosphate inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼